Akebia Therapeutics Inc. (AKBA) gained 5.2% or 0.43 to $8.7. It is close to 162861 shares traded, which is 39.91% compare to the average total volume 408056. The market cap of AKBA is $496.29 million. The year to date change is -39.56%. The 52 week price range is from $7.32 to $20.25. Price of AKBA have changed -0.72% during last week. It have changed 0.12% over last month, -22.71% over last 3 months, -21.80% over last 6 months and -53.80% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKBA is 8.72. It is 0.23% above current price. The stock faces resistance at 50-day moving averages. The 200-day Moving Averages for AKBA is 11.30. It is 29.89% above current price. The 52-week High is 20.25. It is 132.76% from the current price. The 52-week Low is 7.32. It is -15.86% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of AKBA is 9.41 on 2018-09-14. Short % to float is 6.61%. There are some statistics of AKBA. It is has market cap $496.29 million. The share outstanding is 57.05 million. The average volume is 408056. The revenue is 41.28M. The percent of top 15 Institution holding is 57.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKBA is -60.96%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKBA is -18.03%.